ACCESS

From formulary access to patient support programs, we have your patients covered.

CONFIDENCE IN COVERAGE

of commercially insured patients have access to KEVZARA as of 1/1/2020

KEVZARA NATIONAL COVERAGE
KEVZARA is available nationally across multiple plans and segments.
PLAN NAME KEVZARA COVERAGE
STATUS
LIVES IMPACTED
Commercial*
Aetna Covered for use after TWO of the following–
Humira®, Enbrel®, Xeljanz®, Rinvoq™ or Orencia®
9.4 million
Anthem Covered for use after TWO of the following–
Enbrel®, Humira®, Remicade® or Simponl®
13.5 million
Cigna Covered for use after TWO of the following–
Humira®, Enbrel®, Xeljanz®, Actemra® or Rinvoq™
6.5 million
CVS Covered for use after TWO of the following–
Humira®, Enbrel®, Xeljanz®, Rinvoq™ or Orencia®
26 million
ESI Covered for use after TWO of the following–
Humira®, Enbrel®, Actemra®, Xeljanz® or Rinvoq™
40 million
Humana Preferred access: covered for first-line use following cDMARD 1.2 million
TRICARE Covered for use after failure on Humira® 7 million
VA Covered for use after failure on Enbrel® 9.2 million
Medicare*
ESI Covered for use after TWO of the following–
Humira®, Enbrel®, Actemra® or Xeljanz®
1.5 million
Humana Preferred access: covered for first-line use following cDMARD 8.1 million
Managed Medicaid*
Anthem Covered for use after: Enbrel® and Humira® 2.8 million
CVS Preferred Access: covered for first-line use following cDMARD 15 million
  • *Requires prior authorization.

Formulary data are provided by Managed Markets Insights Technology, LLC, and are current as of 1/1/2020.

A majority of patients, 70%, have access to KEVZARA after trying and failing with up to 2 products (double-step edit). KevzaraConnect® is designed to support and simplify the KEVZARA journey for your patients by providing coverage support, including assistance with navigating the complex insurance process.